|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.19 0.00 (0.00%) as of 4:30 Tue 11/15
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,000,000 |
| Market
Cap: |
1.75(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1949 - $0.1949 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SenesTech develops and commercializes a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. Co.'s fertility control product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide. When consumed, ContraPest targets reproduction, limiting fertility in male and female rats beginning with the first breeding cycle following consumption. ContraPest is being marketed for use in controlling rat populations, specifically Norway and roof rats.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2018-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
405,534 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-12-21 |
4 |
AS |
$0.67 |
$4,026 |
D/D |
(6,000) |
386,977 |
|
- |
|
| Dumont Marc |
Director |
• • – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,086 |
3,086 |
|
- |
|
| Williams Julia Ann |
Director |
• • – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,086 |
3,086 |
|
- |
|
| Altman Andrew |
Chief Operating Officer |
• • – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
28,112 |
|
- |
|
| Szot Matthew K |
Director |
• • – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,086 |
3,086 |
|
- |
|
| Wickersham Grover T |
Director |
• • – |
2017-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,086 |
286,686 |
|
- |
|
| Szot Matthew K |
Director |
• • – |
2017-12-18 |
4 |
A |
$0.67 |
$15,000 |
I/I |
22,388 |
56,388 |
|
- |
|
| Wickersham Grover T |
Director |
• • – |
2017-12-18 |
4 |
A |
$0.67 |
$23,450 |
D/D |
35,000 |
283,600 |
|
- |
|
| Wolin Kim Patrice |
EVP & Secretary |
• • – |
2017-12-18 |
4 |
D |
$0.67 |
$8,715 |
D/D |
(13,007) |
30,277 |
|
- |
|
| Wolin Kim Patrice |
EVP & Secretary |
• • – |
2017-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
43,284 |
43,284 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
392,977 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-12-04 |
4 |
AS |
$0.82 |
$4,921 |
D/D |
(6,000) |
387,201 |
|
- |
|
| Williams Julia Ann |
Director |
• • – |
2017-11-24 |
4 |
B |
$0.90 |
$1,525 |
I/I |
1,700 |
23,750 |
2.02 |
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-11-21 |
4 |
AS |
$0.89 |
$5,363 |
D/D |
(6,000) |
397,977 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-11-02 |
4 |
AS |
$2.72 |
$16,339 |
D/D |
(6,000) |
393,201 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-10-20 |
4 |
AS |
$1.52 |
$9,126 |
D/D |
(6,000) |
403,977 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
399,201 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-10-03 |
4 |
AS |
$1.97 |
$11,808 |
D/D |
(6,000) |
439,201 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-09-30 |
4 |
D |
$1.85 |
$9,886 |
D/D |
(5,344) |
445,201 |
|
- |
|
| Dyer Cheryl Ann |
Pres. & Chief Research Officer |
• • – |
2017-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
450,545 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-09-30 |
4 |
D |
$1.85 |
$9,276 |
D/D |
(5,014) |
409,977 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,333 |
414,991 |
|
- |
|
| Mayer Loretta Powers |
CEO & Chief Scientific Officer |
• • – |
2017-09-22 |
4 |
AS |
$1.79 |
$10,740 |
D/D |
(6,000) |
396,658 |
|
- |
|
| Altman Andrew |
Chief Operating Officer |
• • – |
2017-09-19 |
4 |
D |
$1.76 |
$3,323 |
D/D |
(1,888) |
23,112 |
|
- |
|
154 Records found
|
|
Page 4 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
